With two complex CAR T immunotherapies now approved on the NHS in England, we look at how the health service has had to react to these exciting new treatments.
A cancer immunotherapy will be offered on the NHS in England to some adults with aggressive non-Hodgkin lymphoma, NHS England announced today.
A cancer immunotherapy has been provisionally rejected as a treatment for some adults with an aggressive type of non-Hodgkin lymphoma on the NHS in England.
A cancer immunotherapy has been provisionally rejected as a treatment for some types of aggressive non-Hodgkin lymphoma on the NHS in England.
The immunotherapy drug pembrolizumab (Keytruda) can now be used to treat some patients with Hodgkin lymphoma on the NHS in England.
Four in 10 patients with aggressive lymphoma were cancer-free 15 months after treatment with engineered immune cells, according to new clinical trial results.
Combining two different immunotherapy treatments could dramatically improve lymphoma survival.
Find out the burning questions some of our researchers want to answer as they set up their own research teams for the first time.
For World Health Day a cancer survivor shares his story about tackling mental health issues after treatment, and how it inspired a career change.
Our researchers may have found a new way to tap into the power of the immune system to fight cancer. Read about their work